This inventor holds 5 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: The Innovative Contributions of Mingming Li
Introduction
Mingming Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel heterocyclic compounds. With a total of 5 patents to his name, his work is paving the way for advancements in antibiotic treatments.
Latest Patents
Mingming Li's latest patents focus on heterocyclic compounds that provide innovative solutions for medical applications. The inventions include novel heterocyclic compounds characterized by a general formula, along with their pharmaceutically acceptable salts. These compounds are designed for use in pharmaceutical compositions, manufacturing processes, and methods of application as medicaments. Specifically, they are aimed at treating or preventing bacterial infections and related diseases.
Career Highlights
Mingming Li is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there emphasizes the importance of research and development in creating effective medical solutions. His contributions are vital in the ongoing battle against bacterial infections.
Collaborations
Mingming Li collaborates with talented professionals such as Mathis Braendlin and Sandra Marie Joseph Grall-Ulsemer. These collaborations enhance the innovative potential of his projects and contribute to the overall success of their research endeavors.
Conclusion
Mingming Li's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations are instrumental in advancing medical treatments, particularly in combating bacterial infections. His contributions are a testament to the importance of research and development in improving healthcare outcomes.